Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenix Plus and Bone Dust in Metopic Craniosynostosis
NCT01006148Phase 4Withdrawn
- Sponsor
- University of Missouri
- Start
- Oct 2009
- Primary completion
- Aug 2010
- Modality
- Implantable Devices, Tissue Cells
- Countries
- 1
01
Overview
A Phase 4 trial of Allogenix Plus in metopic craniosynostosis, sponsored by University of Missouri. Planned start Oct 2009; status: withdrawn.
02
Drugs
Allogenix Plus
03
Conditions
metopic craniosynostosis
Beyond the preview
Go deeper on NCT01006148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006148.